Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer

Veteran biopharmaceutical executive brings over 30 years of financial, corporate strategy, transactional and business development experienceBOTHELL, Wash., May 22, 2023 -- Athira Pharma,... | May 22, 2023

Related Keywords

Washington ,United States ,Seattle ,Mark Litton ,Athira Pharma ,Julie Rathbun ,Massachusetts Institute Of Technology ,Securities Exchange ,Twitter ,Facebook ,Exchange Commission ,Linkedin ,Nasdaq ,Mckinsey Co ,Technology Associate At Morgan Stanley ,Corporate Development At Amgen ,Anderson School Of Management ,Instagram ,Head Of Corporate Development At Synlogic Inc ,Athira Pharma Inc ,Master Of Business Administration ,Neuraltus Pharmaceuticals ,Andrew Gengos ,Chief Financial Officer ,Chief Business Officer ,Glenna Mileson ,Chief Executive Officer ,Cyteir Therapeutics ,Immunocellular Therapeutics ,Chief Operating Officer ,Corporate Development ,Vice President ,Technology Associate ,Morgan Stanley ,Senior Engagement Manager ,Business Administration ,Chemical Engineering ,Massachusetts Institute ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Media Contact ,Nc Stock Exchange ,News ,Information ,Press Release ,Veteran ,Iopharmaceutical ,Executive ,Rings ,Dover , 0 ,Tears ,F ,Corporate ,Transactional ,End ,Business ,Development ,Bay ,023 ,Thira Atha Us04746l1044 ,